## Answer
(model generated chain of thought explanation)

Given the patient's history of cervical cancer and recent radiotherapy, it is essential to consider her current hematological status carefully.

Firstly, let's review the laboratory test results:
- Hemoglobin (Hb) 10 g/dL: This is below the normal range for adult women (typically considered normal <12 g/dL), indicating anemia.
- Mean corpuscular volume (MCV) 88 Î¼m3: This is within the normal range, suggesting normocytic anemia.
- Leukocyte count 65,000/mm^3: This is slightly elevated but not significantly abnormal for a routine check-up.
- Platelet count 500,000/mm^3: This is within the normal range.

The peripheral blood smear images are not provided in the question. However, based on the information given and typical findings in patients with normocytic anemia after radiotherapy, we can make some educated guesses:

1. **Radiotherapy-induced bone marrow suppression**: The patient's recent history of radiotherapy could be contributing to her anemia by suppressing bone marrow function.
2. **Iron deficiency anemia (IDA)**: Given the patient's low hemoglobin level and normocytic anemia, iron deficiency is a strong possibility.

Considering these points:

- **Option A (Allogeneic stem cell transplantation)** might be too aggressive for routine management without further evidence of severe disease or failure of initial treatments.
- **Option B (Dasatinib)** is not directly relevant to the patient's current hematological status and does not address the likely cause of her anemia.
- **Option C (Phlebotomy)** could help manage iron deficiency by increasing iron stores, but it may not be sufficient on its own for someone with a low hemoglobin level.
- **Option D (Rituximab)** is a monoclonal antibody used in the treatment of certain cancers and autoimmune diseases. It is not typically used to treat anemia or bone marrow suppression.

Given these considerations, the most appropriate next step would be to investigate and manage iron deficiency anemia, which could involve iron supplements, vitamin B12 supplementation (if deficient), and possibly phlebotomy if necessary. However, without access to the peripheral blood smear images, we cannot definitively diagnose IDA or other causes of normocytic anemia.

Therefore, based on the information provided and typical management strategies for patients with normocytic an